JMV 179

Known as: JMV-179, L-Aspartic acid, N-(N-(N-(N-(N-(N-((1,1-dimethylethoxy)carbonyl)-O-sulfo-L-tyrosyl)-L-norleucyl)glycyl)-D-tryptophyl)-L-norleucyl)-, 1-(2-phenylethyl) ester 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2006
012319942006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Cholecystokinin (CCK) in the nervous system has effects opposite to those of opioids. However, the mechanism by which CCK opposes… (More)
Is this relevant?
1996
1996
We have investigated the potential role of gastrin in the regulation of cell growth in human astrocytic tumors. To this end we… (More)
Is this relevant?
1994
1994
The behavioural effects of two cholecystokinin analogues Boc-Tyr(SO3H)-Nle-Gly-Trp-Nle-Asp-Phe-NH2 (JMV 236), a potent CCK… (More)
Is this relevant?
1994
1994
The ability of CCKA antagonists to inhibit full and partial CCK agonists of the rat pancreatic acinar cell CCKA receptor has been… (More)
  • table 1
  • figure I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1994
1994
During the past few years, several antagonist ligands for cholecystokinin (CCK) receptors have been discovered, but the mechanism… (More)
Is this relevant?